MEPE is a novel regulator of growth plate cartilage mineralization
Open Access
- 30 September 2012
- journal article
- Published by Elsevier BV in Bone
- Vol. 51 (3), 418-430
- https://doi.org/10.1016/j.bone.2012.06.022
Abstract
No abstract availableKeywords
Funding Information
- European Calcified Tissue Society
- NIH (R01AR051598-06A2)
- Diabetes UK
- BBSRC
This publication has 71 references indexed in Scilit:
- PHOSPHO1 is essential for mechanically competent mineralization and the avoidance of spontaneous fracturesBone, 2011
- Sclerostin is a locally acting regulator of late-osteoblast/preosteocyte differentiation and regulates mineralization through a MEPE-ASARM-dependent mechanismJournal of Bone and Mineral Research, 2011
- Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: A unified model of the mechanisms of initiation of skeletal calcificationJournal of Bone and Mineral Research, 2011
- Inhibition of PHOSPHO1 activity results in impaired skeletal mineralization during limb development of the chickBone, 2010
- MEPE’s Diverse Effects on MineralizationCalcified Tissue International, 2009
- Matrix Extracellular Phosphoglycoprotein (MEPE) Is a New Bone Renal Hormone and Vascularization ModulatorEndocrinology, 2009
- Genetic Evidence of Serum Phosphate-Independent Functions of FGF-23 on BonePLoS Genetics, 2008
- Degradation of MEPE, DMP1, and Release of SIBLING ASARM-Peptides (Minhibins): ASARM-Peptide(s) Are Directly Responsible for Defective Mineralization in HYPEndocrinology, 2007
- Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatinBone, 2006
- Developmental regulation of the growth plateNature, 2003